22nd Century Group, Inc. (XXII)
NCM · Common · CUSIP 90137F509
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XXII and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
90137F509 (prev. 90137F301 )
Market Cap
Small Cap
Business: 22nd Century Group, Inc. is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and plant breeding.
Notes: June 16, 2025, 22nd Century Group, Inc. (the “Company”) filed a Certificate of Change (the “Certificate”) pursuant to Nevada Revised Statutes (“NRS”) Section 78.209 with the Secretary of State of the State of Nevada authorizing a 1-for-23 reverse stock split of the Company’s (a) authorized shares of common stock; and (b) issued and outstanding shares of common stock (the “Reverse Stock Split”). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on June 20, 2025, and will be reflected with NASDAQ and in the marketplace at the open of business on June 20, 2025 (the “Effective Date”), whereupon the shares of common stock will begin trading on a split-adjusted basis. In connection with the Reverse Stock Split, the Company’s shares of common stock will continue to trade on NASDAQ under the symbol “XXII” but will trade under a new CUSIP Number, 90137F509.

Company Contact

CEO
Larry Firestone
CFO
Dan Otto
Headquarters
321 Farmington Road, Mocksville, NC 27028
Phone
336-940-3769
Fax
716-877-3064
Investor Relations
Matt Kreps · 336-940-3769 · mkreps@xxiicentury.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »